Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Lymphoma Research Foundation (LRF), MYD88 L265P and CXCR4 mutations, BTK (Bruton tyrosine kinase), Ibrutinib and the tag haematologic.
Shares Lymphoma Research Foundation (LRF), Miltenyi Biomedicine, CD79b, Zamtocabtagene autoleucel and the tag haematologic.
Shares BTK (Bruton tyrosine kinase), Ibrutinib, CD20, Rituximab and the tag haematologic.
Shares Lymphoma Research Foundation (LRF), CD79b, Axicabtagene ciloleucel, BTK (Bruton tyrosine kinase) and the tag haematologic.
Shares Lymphoma Research Foundation (LRF), Autologous stem cell transplant (high-dose therapy), PD-1, CAR-T cell therapy and the tag haematologic.
Shares National Brain Tumor Society (NBTS), Brain tumor pathology, CNS oncology, Journal of neuro-oncology and the tag cns.
Shares Lenalidomide and the tag haematologic.
Shares Brain tumor pathology, CNS oncology, Journal of neuro-oncology, Blood-brain barrier (BBB) and the tag cns.
The same record for scripts and assistants; checked 2026-09-08. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.